Living With Cancer


Expanded Access

The drug development process is lengthy, complex and expensive. Treatment options can take more than a decade to get from a research concept to an actual treatment. The evidence may or may not justify approval by the FDA for use by cancer patients. In addition, the drug development process is changing as treatments shift from traditional chemotherapies to options such as biologic drugs and vaccines.

Because the drug development timeline is lengthy, CAN supports compassionate use or expanded access programs which provide experimental treatments to patients once a treatment is shown to be relatively safe and effective.

Our Efforts

top of the page